Taamma A - Search Results

1

A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.

Zelek L, Yovine A, Brain E, Turpin F, Taamma A, Riofrio M, Spielmann M, Jimeno J, Misset JL. Zelek L, et al. Among authors: taamma a. Br J Cancer. 2006 Jun 5;94(11):1610-4. doi: 10.1038/sj.bjc.6603142. Br J Cancer. 2006. PMID: 16736024 Free PMC article. Clinical Trial.

2

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Delaloge S, Yovine A, Taamma A, Riofrio M, Brain E, Raymond E, Cottu P, Goldwasser F, Jimeno J, Misset JL, Marty M, Cvitkovic E. Delaloge S, et al. Among authors: taamma a. J Clin Oncol. 2001 Mar 1;19(5):1248-55. doi: 10.1200/JCO.2001.19.5.1248. J Clin Oncol. 2001. PMID: 11230465 Clinical Trial.

3

Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors.

Taamma A, Misset JL, Riofrio M, Guzman C, Brain E, Lopez Lazaro L, Rosing H, Jimeno JM, Cvitkovic E. Taamma A, et al. J Clin Oncol. 2001 Mar 1;19(5):1256-65. doi: 10.1200/JCO.2001.19.5.1256. J Clin Oncol. 2001. PMID: 11230466 Clinical Trial.

4

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Yovine A, Riofrio M, Blay JY, Brain E, Alexandre J, Kahatt C, Taamma A, Jimeno J, Martin C, Salhi Y, Cvitkovic E, Misset JL. Yovine A, et al. Among authors: taamma a. J Clin Oncol. 2004 Mar 1;22(5):890-9. doi: 10.1200/JCO.2004.05.210. J Clin Oncol. 2004. PMID: 14990645 Clinical Trial.

5

Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

Soulié P, Trandafir L, Taamma A, Lokiec F, Brain E, Delord JP, Mita A, Vannetzel JM, Cvitkovic E, Misset JL. Soulié P, et al. Among authors: taamma a. Anticancer Drugs. 1997 Sep;8(8):763-6. doi: 10.1097/00001813-199709000-00005. Anticancer Drugs. 1997. PMID: 9396620 Clinical Trial.

6

Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study.

van Kesteren C, Cvitkovic E, Taamma A, López-Lázaro L, Jimeno JM, Guzman C, Math t RA, Schellens JH, Misset JL, Brain E, Hillebrand MJ, Rosing H, Beijnen JH. van Kesteren C, et al. Among authors: taamma a. Clin Cancer Res. 2000 Dec;6(12):4725-32. Clin Cancer Res. 2000. PMID: 11156226

7

Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer.

Delaloge S, Laadem A, Taamma A, Chouaki N, Cvitkovic E, Pautier P, Misset JL, Lhommé C. Delaloge S, et al. Among authors: taamma a. Am J Clin Oncol. 2000 Dec;23(6):569-74. doi: 10.1097/00000421-200012000-00007. Am J Clin Oncol. 2000. PMID: 11202798 Clinical Trial.

8

A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion.

van Kesteren C, Mathĵt RA, López-Lázaro L, Cvitkovic E, Taamma A, Jimeno JM, Guzman C, Schellens JH, Misset JL, Brain E, Hillebrand MJ, Rosing H, Beijnen JH. van Kesteren C, et al. Among authors: taamma a. Cancer Chemother Pharmacol. 2001 Dec;48(6):459-66. doi: 10.1007/s002800100368. Cancer Chemother Pharmacol. 2001. PMID: 11800026

9

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.

Hilgers W, Faivre S, Chieze S, Alexandre J, Lokiec F, Goldwasser F, Raymond E, Kahatt C, Taamma A, Weems G, MacDonald JR, Misset JL, Cvitkovic E. Hilgers W, et al. Among authors: taamma a. Invest New Drugs. 2006 Jul;24(4):311-9. doi: 10.1007/s10637-005-5055-6. Invest New Drugs. 2006. PMID: 16683074 Clinical Trial.

10

Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type.

Fandi A, Taamma A, Azli N, Bachouchi M, Yanes B, Armand JP, Cvitkovic E. Fandi A, et al. Among authors: taamma a. Head Neck. 1997 Jan;19(1):41-7. doi: 10.1002/(sici)1097-0347(199701)19:1<41::aid-hed8>3.0.co;2-v. Head Neck. 1997. PMID: 9030944 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters